APA (7th ed.) Citation

J, E., LJ, N., M, R., J, M., DS, L., C, S., . . . T, B. (2025). Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: A phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 380(1938), 20240402. https://doi.org/10.1098/rstb.2024.0402

Chicago Style (17th ed.) Citation

J, Ellis, et al. "Valganciclovir for Cytomegalovirus Viraemia in Advanced HIV Disease: A Phase 2b Randomized Placebo-controlled Trial of Valganciclovir for Cytomegalovirus Viraemia in Adults and Adolescents with Advanced HIV Disease." Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 380, no. 1938 (2025): 20240402. https://doi.org/10.1098/rstb.2024.0402.

MLA (9th ed.) Citation

J, Ellis, et al. "Valganciclovir for Cytomegalovirus Viraemia in Advanced HIV Disease: A Phase 2b Randomized Placebo-controlled Trial of Valganciclovir for Cytomegalovirus Viraemia in Adults and Adolescents with Advanced HIV Disease." Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 380, no. 1938, 2025, p. 20240402, https://doi.org/10.1098/rstb.2024.0402.